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Serum apolipoprotein B/A1 (apo B/A1) ratio has been known for strong
predictor of cardiovascular disease (CVD). Measuring carotid artery
intimal-medial thickness (CIMT) is non-invasive modality used to evaluate
subclinical atherosclerosis and to predict future cardiovascular disease. The
objective of this study is to evaluate the association between apo B/A1 and
CIMT in chronic kidney disease (CKD).We retrospectively reviewed the 293
patients who had visited health promotion center in a single community.
The patients were divided into 2 group which are CKD group (n¼99,
estimated glomerular ﬁltration rate (eGFR): 15-59 mL/min) and non-CKD
group (n¼194, eGFR Z 60 mL/min). Age, sex, presence of diabetes mellitus
(DM)/hypertension, smoking status, eGFR, body mass index, and various
biochemical blood examinations (serum LDL/HDL cholesterol, serum
homocystein, and serum apo B/A1 ratio) were evaluated in each patient.
CIMT was measured by high-resolution B-mode ultrasonography.
Multivariate linear regression analysis was performed to investigate which
factors are associated with CIMT in each of 2 groups. In CKD group, age
(b¼0.163, p¼0.024), presence of hypertension (b¼0.208, p¼0.006), and
presence of DM (b¼0.236, p¼0.002) were independently associated with
CIMT adjustment for other confounding factors. However, in CKD group,
serum apo B/A1 (b¼0.572, po0.001), presence of HTN (b¼0.360,
p¼0.001), and presence of DM (b¼0.194 p¼0.023) contributed to CIMT
independently after adjustment for other confounding factors.
In conclusion, this study showed serum apo B/A1 ratio was
independently associated with CIMT only in CKD group, not in non-CKD
group. Because CIMT is a strong predictor of CVD, the result of this study
demonstrates serum apo B/A1 ratio could be included in cardiovascular
risk stratiﬁcation in CKD patients
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patients are considered to be physically less activity than normal, but there
are only few studies on this question. We measured DPA over 7 days, with the
new Actigraph GT3Xþ Activity Monitors, on 63 patients receiving MHD
3Xwk for Z6 months and 36 matched normals. Patients were 52714SD
years, 30% female; 35% diabetic; dialysis vintage, 61747 mos. Normals were
49712 years, 42% female, with similar racial/ethnic mix. The average daily
vector magnitude for DPA, calculated as the square root of the sum of the
squares of the three dimensional axes, was much lower in MHD, 398,868
counts (counts include HD days), vs. Normals (651,685 counts, Po0.001). In
MHD vs Normals, % time in sleep or marked physical inactivity was 81% vs
73% (Po0.001); % time in Zmoderate activity, 4.0% vs 7.0% (Po0.001). In
MHD, there was a trend toward increasing physical activity as patients
progressed from the HD day to one day and then two days post-HD (Two days
post-HD vs. HD day, p¼0.015). This trend might be due to reduced activity inthe HD unit, increased physical activity on weekends, or exhaustion from HD.
Thus, compared to matched normal adults, MHD patients have markedly
reduced DPA. Since study subjects had to be willing and able to complete
physical performance tests, the most debilitated MHD patients were not
recruited to the study. Hence, decreased DPA in MHD patients might be even
greater than observed.
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Bioimpedance analysis is a reliable technique for determining post dialysis
target weight. Using this technique, we can understand body ﬂuid status easier
and conveniently. Moreover this technique can be used for check nutrition
status and nutritional status of dialysis patients. We compared the body ﬂuid
status and nutrition status between hemodialysis (HD) patients and peritoneal
dialysis (PD) patients by BCM (Body composition monitor) technique. We
studied 48 (30 males and 18 females) PD patients, 21 (10 males and 11
females) HD patients. Body composition monitoring (BCM, Fesenitus Medical
Care, Germany) was used as a tool for the analysis of bioimpedance.
Extracellular water, Total body water, Intracellular water, Overhydration, E/I,
Lean tissue mass, Fat Tissue mass was measured and those results were
compared between two groups. HD patients were more hydrated than PD
patients (61.9% vs. 35.4%) and nutritional status such as LTI was poorer than
peritoneal dialysis patients (11.771.7 vs. 15.372.6). Although total body
water is more abundant in peritoneal patients (29.475.5L vs. 35.976.2L),
Extracellular water and intracellular water ratio was relatively higher in
Hemodialysis patients (E/I 0.9870.13 vs. 0.8770.12). The nutrition status was
better in PD patients by comparing the percent of lean tissue mass (LTM%)
between two groups (LTM% 52.1710.6% vs. 66.8711.3). In conclusions,
Hemodialysis patients were more hydrated with poorer nutrition status than
peritoneal dialysis patients, but, due to the signiﬁcant difference of age between
two groups, further study should be required.
http://dx.doi.org/10.1016/j.krcp.2012.04.443120
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The main osmotic agent found in the peritoneal dialysis (PD) solution is
glucose. It has been of a wide use for great crystalloid osmotic power at a low
concentration, simple metabolism, and excellent safety. On the other hand,
anywhere between 60 to 80% of the glucose in the PD solution is absorbed - a
100 to 300 mg of daily glucose absorption. Once into the systemic circulation,
glucose can be a cause for metabolic complications including obesity. Indeed,
the diabetiform change observed in the peritoneal membrane in the long-term
PD patients is believed attributable to the high-concentration glucose in the PD
solution. The glucose absorbed from peritoneal cavity raises the risk of ‘glucose
toxicity’, leading to insulin resistance and beta cell failure. Clinical similarity can
be found in postprandial hyperglycemia, which is known to be associated with
oxidative stress, endothelial dysfunction, NF-kb, and inﬂammation, affecting
myocardial blood ﬂow. Moreover, it is a proven independent risk factor of
coronary artery disease in patients with type 2 diabetes, particularly of female
gender. Though speculative yet, glucose toxicity might explain a higher
mortality of PD patients after the ﬁrst year compared with those on
hemodialysis (more so in female, advanced-age patients with diabetes). Also
included in the picture are glucose degradation products (GDPs) generated
along the course of heat sterilization or storage of the PD solution. They have
been shown to induce apoptosis of peritoneal mesothelial cells, renal tubular
